Presentation

TCT 3: Pretreatment With P2Y12 Receptor Antagonists Is Not Associated With Improved Patency of Infarct Related-Artery in STEMI A Report from SCAAR

Presenter: Elmir Omerovic

October 31, 2016

REGISTER for free or LOG IN to view this content

TCT 3: Pretreatment With P2Y12 Receptor Antagonists Is Not Associated With Improved Patency of Infarct Related-Artery in STEMI – A Report from SCAAR

Coronary

Presentation

TCT 2016

ACS/AMI

Up Next

Presentation

The FDA Town Hall Meeting: Evolution of a Decades Long Collaboration Between Physician-Scientists, Industry, Regulators, and Payors

Presenter: Gregg W. Stone

October 31, 2016

More slides +

Presentation

Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Daniel Burkhoff

October 31, 2016

Presentation

Key Note Lecture I. FDA/CDRH State of the Union

Presenter: Jeffrey Shuren

October 31, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.